Junhui Sun
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Hepatology 27
- Hepatocellular Carcinoma Treatment and Prognosis 25
- Liver Disease and Transplantation 4
- Liver physiology and pathology 3
-
- Angiogenesis and VEGF in Cancer 7
- Epigenetics and DNA Methylation 5
- Co-authors
- Shusen Zheng (15 shared papers)Guan‐Hui Zhou (16 shared papers)Tong‐Yin Zhu (15 shared papers)Chun‐Hui Nie (16 shared papers)Fuliang Li (1 shared paper)Jiaping Li (1 shared paper)Wenquan Zhuang (1 shared paper)Zhenwei Peng (1 shared paper)
- Journals
- Frontiers in Oncology (4 papers)Oncotarget (3 papers)BioMed Research International (2 papers)Cell Transplantation (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Junhui Sun
65 papers receiving 1.2k citations
Junhui Sun's Hit Papers
Peers
Comparison fields: 5 of 85
- Hepatology 569
- Cancer Research 107
- Biotechnology 59
- Health Informatics 9
- Pathology and Forensic Medicine 89
Countries citing papers authored by Junhui Sun
This map shows the geographic impact of Junhui Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhui Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhui Sun more than expected).
Fields of papers citing papers by Junhui Sun
This network shows the impact of papers produced by Junhui Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhui Sun. The network helps show where Junhui Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Junhui Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) Hit paper breakdown → | 2022 | 286 |
| 2 | 2006 | 73 | |
| 3 | 2023 | 58 | |
| 4 | 2015 | 50 | |
| 5 | 2018 | 48 | |
| 6 | 2015 | 37 | |
| 7 | 2023 | 37 | |
| 8 | 2022 | 37 | |
| 9 | 2020 | 35 | |
| 10 | 2008 | 30 | |
| 11 | 2020 | 29 | |
| 12 | 2017 | 28 | |
| 13 | 2009 | 26 | |
| 14 | 2023 | 23 | |
| 15 | 2012 | 22 | |
| 16 | 2023 | 21 | |
| 17 | 2020 | 16 | |
| 18 | 2012 | 16 | |
| 19 | 2016 | 15 | |
| 20 | 2023 | 14 |
About Junhui Sun
Junhui Sun is a scholar working on Hepatology, Molecular Biology, Surgery, Epidemiology and Biotechnology, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Angiogenesis and VEGF in Cancer (7 papers), Epigenetics and DNA Methylation (5 papers), Mesenchymal stem cell research (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Microbial Inactivation Methods (4 papers), Liver Disease and Transplantation (4 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Hepatology (569 citations), Cancer Research (107 citations), Biotechnology (59 citations), Health Informatics (9 citations) and Pathology and Forensic Medicine (89 citations). Junhui Sun has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Shusen Zheng, Guan‐Hui Zhou, Tong‐Yin Zhu, Chun‐Hui Nie, Fuliang Li, Jiaping Li, Wenquan Zhuang, Zhenwei Peng, Fuxi Huang and Liangliang Qiao. Their work appears in journals such as Frontiers in Oncology, Oncotarget, BioMed Research International, Cell Transplantation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.